Natalie Stevens

  • 140 Citations
  • 5 h-Index
20132019
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Natalie began her scientific career with a Bachelor of Laboratory Medicine (Honours) at the University of South Australia and was awarded first-class honours in 2011 for her project within the Experimental Therapeutics Laboratory, which concerned the development of antibody therapeutics for influenza treatment. She continued her studies with a PhD where she evaluated passive immunotherapy approaches targeting high mobility group box protein 1 in sepsis, with a particular focus on the impact of this therapy on post-septic immunosuppression. In 2016 Natalie took on a postdoctoral role at the University of South Australia Future Industries Institute where she worked with industry to develop antibody therapies for the treament of the rare skin blistering disorders. In 2019, Natalie joined the Lynn EMBL Computational and Systems Biology Laboratory as a Postdoctoral Researcher in Immunology, where she works to understand the consequences of immune challenges on longterm innate immune function and pathogen defence. Natalie is passionate about evidence-based medicine, communicating science to the public and advocating for science literacy.

Education/Academic qualification

PhD, University of South Australia

Bachelor's Degree (Honours), University of South Australia

External positions

Research Associate, University of South Australia

25 Jul 201614 Apr 2019

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 140 Citations
  • 5 h-Index
  • 11 Article

Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin

Stevens, N. E., Cowin, A. J. & Kopecki, Z., 2019, In : Frontiers in Immunology. 10, p. 1089 1 p.

Research output: Contribution to journalArticle

Flightless I alters the inflammatory response and autoantibody profile in an OVA-induced atopic dermatitis skin-like disease

Kopecki, Z., Stevens, N. E., Chong, H. T., Yang, G. N. & Cowin, A. J., 10 Aug 2018, In : Frontiers in Immunology. 9, AUG, 1833.

Research output: Contribution to journalArticle

1 Citation (Scopus)
16 Citations (Scopus)

Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes

Stevens, N. E., Chapman, M. J., Fraser, C., Kuchel, T., Hayball, J. D. & Diener, K. R., 1 Dec 2017, In : Scientific Reports. 7, 1, 5850.

Research output: Contribution to journalArticle